Table 1.
Patient characteristics.
| Characteristics | BDC+Chemotherapy | CDC+Chemotherapy | P value |
|---|---|---|---|
| Mean age (years) | 58.7 ± 15.6 | 61.6 ± 12.0 | 0.46* |
| Sex | 0.24# | ||
| Female | 16 | 12 | |
| Male | 8 | 12 | |
| Time to diagnosis | 22.5 ± 9.0 | 26.3 ± 11.5 | 0.21* |
| Biliary stenosis length (mm) | 31.2 ± 5.6 | 29.9 ± 5.5 | 0.44* |
| Local tumor diameter (mm) | 27.0 ± 10.1 | 25.8 ± 8.6 | 0.65* |
| Clinical stage | 0.81# | ||
| I | 2 | 3 | |
| II | 8 | 7 | |
| III | 11 | 9 | |
| IV | 3 | 5 | |
| ECOG score | 0.19# | ||
| 1 | 11 | 15 | |
| 2 | 13 | 9 | |
| CA19-9 (U/mL) | 723.5 ± 697.8 | 683.2 ± 693.2 | 0.84* |
| Laboratory values | |||
| White blood cell (×109/L) | 6.2 ± 1.4 | 6.4 ± 1.7 | 0.62* |
| Hemoglobin (g/L) | 118.5 ± 29.1 | 127.4 ± 18.0 | 0.21* |
| Serum bilirubin (µmol/L) | 180.5 ± 53.7 | 169.4 ± 58.5 | 0.50* |
| Direct bilirubin (µmol/L) | 136.7 ± 46.8 | 134.9 ± 50.5 | 0.90* |
| Albumin (g/L) | 38.7 ± 2.7 | 39.0 ± 2.9 | 0.71* |
| Alanine aminotransferase (U/L) | 105.9 ± 44.5 | 91.9 ± 40.6 | 0.26* |
| Alkaline phosphatase (U/L) | 642.8 ± 335.4 | 614.8 ± 297.0 | 0.76* |
| Chemotherapy course | 0.73# | ||
| 2–4 | 18 | 19 | |
| 4-6 | 6 | 5 |
Data shown are the number or mean ± SD; * Independent samples t-test was used; # χ2 test was used.